RXST Stock Analysis: Buy, Sell, or Hold?
RXST - RxSight, Inc. Common Stock
$8.69
-0.22 (-2.47%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When RXST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called RXST this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RXST shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RXST shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RXST is currently trading at $8.69, which is considered oversold relative to its 30-day fair value range of $9.20 to $10.83.
Technical Outlook: Technically, RXST is in a uptrend. The price is currently testing key support at $8.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RXST has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.50 (+17.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RXST is in a uptrend. The price is currently testing key support at $8.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RXST has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.50 (+17.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$9.20 -
$10.83
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
Protect Your Profits
Holding RXST? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($10.50)
- CAUTION: 5-day price weakness (-8.6%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$9.20 -
$10.83
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$8.86
Resistance Level
$10.16
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-17.55
Wall Street Target
$10.50
(+17.8%)
Revenue Growth (YoY)
-14.1%
Profit Margin
-25.1%
Last updated: January 31, 2026 2:35 PM ET
Data refreshes hourly during market hours. Next update: 3:35 PM
Data refreshes hourly during market hours. Next update: 3:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RXST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced RXST Option Strategies
Professional options setups generated by AI based on today's RXST price and gamma walls.
